The role of ubiquitin ligases in cardiac disease

Journal of Molecular and Cellular Cardiology

Volumn 71, Issue , 2014, Pages 43-53

  Willis, Monte S ^a   Bevilacqua, Ariana ^a   Pulinilkunnil, Thomas ^b   Kienesberger, Petra ^b   Tannu, Manasi ^a   Patterson, Cam ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Cardiac; Cardiomyopathy; Heart failure; Ischemic heart disease; Proteasome; Ubiquitin ligase

Indexed keywords

BETA ADRENERGIC RECEPTOR; CONNEXIN 43; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MUSCLE RING FINGER 1 PROTEIN; UBIQUITIN PROTEIN LIGASE; UBIQUITIN PROTEIN LIGASE NEDD4; PROTEASOME; UBIQUITIN;

APOPTOSIS; CELL FUSION; ENZYME ACTIVITY; ETHER A GO GO RELATED GENE; GAP JUNCTION; GENE; HEART DISEASE; HEART FAILURE; HEART INFARCTION; HEART MUSCLE ATROPHY; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART VENTRICLE HYPERTROPHY; HUMAN; INTRACELLULAR SIGNALING; MEMBRANE BIOLOGY; MITOCHONDRIAL FISSION; MITOPHAGY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN METABOLISM; PROTEIN PROTEIN INTERACTION; PROTEIN UNFOLDING; REPERFUSION INJURY; REVIEW; UBIQUITINATION; ANIMAL; ENZYMOLOGY; METABOLISM;

ANIMALS; HEART DISEASES; HUMANS; MYOCYTES, CARDIAC; PROTEASOME ENDOPEPTIDASE COMPLEX; UBIQUITIN; UBIQUITIN-PROTEIN LIGASES;

EID: 84899986849     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2013.11.008     Document Type: Review

References (128)

1. Willis M.S., Schisler J.C., Portbury A.L., Patterson C. Build it up-tear it down: protein quality control in the cardiac sarcomere. Cardiovasc Res 2009, 81:439-448.
2. Rock K.L., Gramm C., Rothstein L., Clark K., Stein R., Dick L., et al. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell 1994, 78:761-771.
3. Baehrecke E.H. Autophagy: dual roles in life and death?. Nat Rev Mol Cell Biol 2005, 6:505-510.
4. Lardeux B.R., Mortimore G.E. Amino acid and hormonal control of macromolecular turnover in perfused rat liver. Evidence for selective autophagy. J Biol Chem 1987, 262:14514-14519.
5. Willis M.S., Patterson C. Into the heart: the emerging role of the ubiquitin-proteasome system. J Mol Cell Cardiol 2006, 41:567-579.
6. Willis M.S., Townley-Tilson W.H., Kang E.Y., Homeister J.W., Patterson C. Sent to destroy: the ubiquitin proteasome system regulates cell signaling and protein quality control in cardiovascular development and disease. Circ Res 2010, 106:463-478.
7. Spaich S., Will R.D., Just S., Spaich S., Kuhn C., Frank D., et al. F-box and leucine-rich repeat protein 22 is a cardiac-enriched F-box protein that regulates sarcomeric protein turnover and is essential for maintenance of contractile function in vivo. Circ Res 2012, 111:1504-1516.
8. Samarel A.M., Parmacek M.S., Magid N.M., Decker R.S., Lesch M. Protein synthesis and degradation during starvation-induced cardiac atrophy in rabbits. Circ Res 1987, 60:933-941.
9. Coleman P.S., Parmacek M.S., Lesch M., Samarel A.M. Protein synthesis and degradation during regression of thyroxine-induced cardiac hypertrophy. J Mol Cell Cardiol 1989, 21:911-925.
10. Parmacek M.S., Magid N.M., Lesch M., Decker R.S., Samarel A.M. Cardiac protein synthesis and degradation during thyroxine-induced left ventricular hypertrophy. Am J Physiol 1986, 251:C727-C736.
11. Arya R., Kedar V., Hwang J.R., McDonough H., Li H.H., Taylor J., et al. Muscle ring finger protein-1 inhibits PKC{epsilon} activation and prevents cardiomyocyte hypertrophy. J Cell Biol 2004, 167:1147-1159.
12. Willis M.S., Ike C., Li L., Wang D.Z., Glass D.J., Patterson C. Muscle ring finger 1, but not muscle ring finger 2, regulates cardiac hypertrophy in vivo. Circ Res 2007, 100:456-459.
13. Wenhao Baskin K.K.C., Salazar Rebecca, Taegtmeyer Heinrich Abstract 3210: the ubiquitin ligase atrogin-1, but not MuRF1, is required for atrophic remodeling of the heart. Circulation 2009, 120.
14. Willis M.S., Rojas M., Li L., Selzman C.H., Tang R.H., Stansfield W.E., et al. Muscle ring finger 1 mediates cardiac atrophy in vivo. Am J Physiol Heart Circ Physiol 2009, 296:H997-H1006.
15. Le N.T., Takei Y., Shishido T., Woo C.H., Chang E., Heo K.S., et al. p90RSK targets the ERK5-CHIP ubiquitin E3 ligase activity in diabetic hearts and promotes cardiac apoptosis and dysfunction. Circ Res 2012, 110:536-550.
16. Zhang C., Xu Z., He X.R., Michael L.H., Patterson C. CHIP, a cochaperone/ubiquitin ligase that regulates protein quality control, is required for maximal cardioprotection after myocardial infarction in mice. Am J Physiol Heart Circ Physiol 2005, 288:H2836-H2842.
17. Toth A., Nickson P., Qin L.L., Erhardt P. Differential regulation of cardiomyocyte survival and hypertrophy by MDM2, an E3 ubiquitin ligase. J Biol Chem 2006, 281:3679-3689.
18. Hwang J.R., Zhang C., Patterson C. C-terminus of heat shock protein 70-interacting protein facilitates degradation of apoptosis signal-regulating kinase 1 and inhibits apoptosis signal-regulating kinase 1-dependent apoptosis. Cell Stress Chaperones 2005, 10:147-156.
19. Preedy V.R., Smith D.M., Kearney N.F., Sugden P.H. Rates of protein turnover in vivo and in vitro in ventricular muscle of hearts from fed and starved rats. Biochem J 1984, 222:395-400.
20. Mostow W.R., Ferguson A.G., Lesch M., Decker R.S., Samarel A.M. Nonrandom turnover of actin and tubulin in cultured rabbit cardiac fibroblasts. Am J Physiol 1988, 255:C202-C213.
21. Eble D.M., Spragia M.L., Ferguson A.G., Samarel A.M. Sarcomeric myosin heavy chain is degraded by the proteasome. Cell Tissue Res 1999, 296:541-548.
22. Bodine S.C., Latres E., Baumhueter S., Lai V.K., Nunez L., Clarke B.A., et al. Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 2001, 294:1704-1708.
23. Kim H.T., Kim K.P., Lledias F., Kisselev A.F., Scaglione K.M., Skowyra D., et al. Certain pairs of ubiquitin-conjugating enzymes (E2s) and ubiquitin-protein ligases (E3s) synthesize nondegradable forked ubiquitin chains containing all possible isopeptide linkages. J Biol Chem 2007, 282:17375-17386.
24. Mohapatra B., Jimenez S., Lin J.H., Bowles K.R., Coveler K.J., Marx J.G., et al. Mutations in the muscle LIM protein and alpha-actinin-2 genes in dilated cardiomyopathy and endocardial fibroelastosis. Mol Genet Metab 2003, 80:207-215.
25. Faulkner G., Lanfranchi G., Valle G. Telethonin and other new proteins of the Z-disc of skeletal muscle. IUBMB Life 2001, 51:275-282.
26. Gupta V., Discenza M., Guyon J.R., Kunkel L.M., Beggs A.H. Alpha-actinin-2 deficiency results in sarcomeric defects in zebrafish that cannot be rescued by alpha-actinin-3 revealing functional differences between sarcomeric isoforms. FASEB J 2012, 26:1892-1908.
27. Chiu C., Bagnall R.D., Ingles J., Yeates L., Kennerson M., Donald J.A., et al. Mutations in alpha-actinin-2 cause hypertrophic cardiomyopathy: a genome-wide analysis. J Am Coll Cardiol 2010, 55:1127-1135.
28. Fujita M., Mitsuhashi H., Isogai S., Nakata T., Kawakami A., Nonaka I., et al. Filamin C plays an essential role in the maintenance of the structural integrity of cardiac and skeletal muscles, revealed by the medaka mutant zacro. Dev Biol 2012, 361:79-89.
29. Selcen D. Myofibrillar myopathies. Curr Opin Neurol 2008, 21:585-589.
30. Selcen D., Carpen O. The z-disk diseases. Adv Exp Med Biol 2008, 642:116-130.
31. Rafiq K., Guo J., Vlasenko L., Guo X., Kolpakov M.A., Sanjay A., et al. c-Cbl ubiquitin ligase regulates focal adhesion protein turnover and myofibril degeneration induced by neutrophil protease cathepsin G. J Biol Chem 2012, 287:5327-5339.
32. Eble D.M., Strait J.B., Govindarajan G., Lou J., Byron K.L., Samarel A.M. Endothelin-induced cardiac myocyte hypertrophy: role for focal adhesion kinase. Am J Physiol Heart Circ Physiol 2000, 278:H1695-H1707.
33. Hakim Z.S., DiMichele L.A., Rojas M., Meredith D., Mack C.P., Taylor J.M. FAK regulates cardiomyocyte survival following ischemia/reperfusion. J Mol Cell Cardiol 2009, 46:241-248.
34. Cheng Z., DiMichele L.A., Hakim Z.S., Rojas M., Mack C.P., Taylor J.M. Targeted focal adhesion kinase activation in cardiomyocytes protects the heart from ischemia/reperfusion injury. Arterioscler Thromb Vasc Biol 2012, 32:924-933.
35. Doherty J.T., Conlon F.L., Mack C.P., Taylor J.M. Focal adhesion kinase is essential for cardiac looping and multichamber heart formation. Genesis 2010, 48:492-504.
36. Zajac B., Hakim Z.S., Cameron M.V., Smithies O., Taylor J.M. Quantification of myocyte chemotaxis: a role for FAK in regulating directional motility. Methods Mol Biol 2012, 843:111-123.
37. Warren S.A., Briggs L.E., Zeng H., Chuang J., Chang E.I., Terada R., et al. Myosin light chain phosphorylation is critical for adaptation to cardiac stress. Circulation 2012, 126:2575-2588.
38. Minicucci M.F., Azevedo P.S., Polegato B.F., Paiva S.A., Zornoff L.A. Heart failure after myocardial infarction: clinical implications and treatment. Clin Cardiol 2011, 34:410-414.
39. Thygesen K., Alpert J.S., Jaffe A.S., Simoons M.L., Chaitman B.R., White H.D., et al. Third universal definition of myocardial infarction. J Am Coll Cardiol 2012, 60:1581-1598.
40. Ma Y., Halade G.V., Lindsey M.L. Extracellular matrix and fibroblast communication following myocardial infarction. J Cardiovasc Transl Res 2012, 5:848-857.
41. Portbury A.L., Ronnebaum S.M., Zungu M., Patterson C., Willis M.S. Back to your heart: ubiquitin proteasome system-regulated signal transduction. J Mol Cell Cardiol 2012, 52:526-537.
42. Decker R.S., Wildenthal K. Lysosomal alterations in hypoxic and reoxygenated hearts. I. Ultrastructural and cytochemical changes. Am J Pathol 1980, 98:425-444.
43. Wildenthal K., Decker R.S. The role of lysosomes in the heart. Adv Myocardiol 1980, 2:349-358.
44. Rifki O.F., Hill J.A. Cardiac autophagy: good with the bad. J Cardiovasc Pharmacol 2012, 60:248-252.
45. Dong Y., Undyala V.V., Gottlieb R.A., Mentzer R.M., Przyklenk K. Autophagy: definition, molecular machinery, and potential role in myocardial ischemia-reperfusion injury. J Cardiovasc Pharmacol Ther 2010, 15:220-230.
46. Gottlieb R.A., Mentzer R.M. Autophagy during cardiac stress: joys and frustrations of autophagy. Annu Rev Physiol 2010, 72:45-59.
47. Gustafsson A.B., Gottlieb R.A. Autophagy in ischemic heart disease. Circ Res 2009, 104:150-158.
48. Chen Y., Dorn G.W. PINK1-phosphorylated mitofusin 2 is a parkin receptor for culling damaged mitochondria. Science 2013, 340:471-475.
49. Huang C., Andres A.M., Ratliff E.P., Hernandez G., Lee P., Gottlieb R.A. Preconditioning involves selective mitophagy mediated by Parkin and p62/SQSTM1. PLoS One 2011, 6:e20975.
50. Boncoraglio A., Minoia M., Carra S. The family of mammalian small heat shock proteins (HSPBs): implications in protein deposit diseases and motor neuropathies. Int J Biochem Cell Biol 2012, 44:1657-1669.
51. Cornelussen R.N., Vanagt W.Y., Prinzen F.W., Snoeckx L.H. Proteins involved in salvage of the myocardium. Adv Exp Med Biol 2003, 543:277-291.
52. Knowlton A.A., Kapadia S., Torre-Amione G., Durand J.B., Bies R., Young J., et al. Differential expression of heat shock proteins in normal and failing human hearts. J Mol Cell Cardiol 1998, 30:811-818.
53. Willis M.S., Patterson C. Hold me tight: role of the heat shock protein family of chaperones in cardiac disease. Circulation 2010, 122:1740-1751.
54. Delogu G., Signore M., Mechelli A., Famularo G. Heat shock proteins and their role in heart injury. Curr Opin Crit Care 2002, 8:411-416.
55. Ballinger C.A., Connell P., Wu Y., Hu Z., Thompson L.J., Yin L.Y., et al. Identification of CHIP, a novel tetratricopeptide repeat-containing protein that interacts with heat shock proteins and negatively regulates chaperone functions. Mol Cell Biol 1999, 19:4535-4545.
56. Connell P., Ballinger C.A., Jiang J., Wu Y., Thompson L.J., Hohfeld J., et al. The co-chaperone CHIP regulates protein triage decisions mediated by heat-shock proteins. Nat Cell Biol 2001, 3:93-96.
57. Jiang J., Ballinger C.A., Wu Y., Dai Q., Cyr D.M., Hohfeld J., et al. CHIP is a U-box-dependent E3 ubiquitin ligase: identification of Hsc70 as a target for ubiquitylation. J Biol Chem 2001, 276:42938-42944.
58. Richardson P.J., Patel V.B., Preedy V.R. Alcohol and the myocardium. Novartis Found Symp 1998, 216:35-45. [discussion -50].
59. Rylander M.N., Feng Y., Bass J., Diller K.R. Thermally induced injury and heat-shock protein expression in cells and tissues. Ann N Y Acad Sci 2005, 1066:222-242.
60. Li F., Xie P., Fan Y., Zhang H., Zheng L., Gu D., et al. C terminus of Hsc70-interacting protein promotes smooth muscle cell proliferation and survival through ubiquitin-mediated degradation of FoxO1. J Biol Chem 2009, 284:20090-20098.
61. Xie P., Fan Y., Zhang H., Zhang Y., She M., Gu D., et al. CHIP represses myocardin-induced smooth muscle cell differentiation via ubiquitin-mediated proteasomal degradation. Mol Cell Biol 2009, 29:2398-2408.
62. Yang K., Zhang T.P., Tian C., Jia L.X., Du J., Li H.H. Carboxyl terminus of heat shock protein 70-interacting protein inhibits angiotensin II-induced cardiac remodeling. Am J Hypertens 2012, 25:994-1001.
63. Naito A.T., Okada S., Minamino T., Iwanaga K., Liu M.L., Sumida T., et al. Promotion of CHIP-mediated p53 degradation protects the heart from ischemic injury. Circ Res 2010, 106:1692-1702.
64. Willis M.S., Min J.N., Wang S., McDonough H., Lockyer P., Wadosky K.M., et al. Carboxyl terminus of Hsp70-interacting protein (CHIP) is required to modulate cardiac hypertrophy and attenuate autophagy during exercise. Cell Biochem Funct Apr. 2 2013, http://dx.doi.org/10.1002/cbf.2962 [Epub ahead of print].
65. Bayeva M., Gheorghiade M., Ardehali H. Mitochondria as a therapeutic target in heart failure. J Am Coll Cardiol 2013, 61:599-610.
66. Zungu M., Schisler J., Willis M.S. All the little pieces. Regulation of mitochondrial fusion and fission by ubiquitin and small ubiquitin-like modifer and their potential relevance in the heart. Circ J 2011, 75:2513-2521.
67. Dorn Ii G.W. Mitochondrial dynamism and cardiac fate. Circ J 2013, 77:1370-1379.
68. Kim H., Scimia M.C., Wilkinson D., Trelles R.D., Wood M.R., Bowtell D., et al. Fine-tuning of Drp1/Fis1 availability by AKAP121/Siah2 regulates mitochondrial adaptation to hypoxia. Mol Cell 2011, 44:532-544.
69. Anton F., Dittmar G., Langer T., Escobar-Henriques M. Two deubiquitylases act on mitofusin and regulate mitochondrial fusion along independent pathways. Mol Cell 2013, 49:487-498.
70. Zhu M., Zhao W., Vazquez N., Mitroka J.G. Analysis of low level radioactive metabolites in biological fluids using high-performance liquid chromatography with microplate scintillation counting: method validation and application. J Pharm Biomed Anal 2005, 39:233-245.
71. Ryall J.G., Sillence M.N., Lynch G.S. Systemic administration of beta2-adrenoceptor agonists, formoterol and salmeterol, elicit skeletal muscle hypertrophy in rats at micromolar doses. Br J Pharmacol 2006, 147:587-595.
72. Tevaearai H.T., Eckhart A.D., Walton G.B., Keys J.R., Wilson K., Koch W.J. Myocardial gene transfer and overexpression of beta2-adrenergic receptors potentiates the functional recovery of unloaded failing hearts. Circulation 2002, 106:124-129.
73. Birks E.J., Tansley P.D., Hardy J., George R.S., Bowles C.T., Burke M., et al. Left ventricular assist device and drug therapy for the reversal of heart failure. N Engl J Med 2006, 355:1873-1884.
74. Zhang W., Yano N., Deng M., Mao Q., Shaw S.K., Tseng Y.T. beta-Adrenergic receptor-PI3K signaling crosstalk in mouse heart: elucidation of immediate downstream signaling cascades. PLoS One 2011, 6:e26581.
75. Zaglia T., Milan G., Franzoso M., Bertaggia E., Pianca N., Piasentini E., et al. Cardiac sympathetic neurons provide trophic signal to the heart via beta2-adrenoceptor-dependent regulation of proteolysis. Cardiovasc Res 2013, 97:240-250.
76. Rudolf R., Bogomolovas J., Strack S., Choi K.R., Khan M.M., Wagner A., et al. Regulation of nicotinic acetylcholine receptor turnover by MuRF1 connects muscle activity to endo/lysosomal and atrophy pathways. Age (Dordr) Oct. 2013, 35(5):1663-1674. http://dx.doi.org/10.1007/s11357-012-9468-9 [Epub 2012 Sep 6].
77. Guo J., Wang T., Li X., Shallow H., Yang T., Li W., et al. Cell surface expression of human ether-a-go-go-related gene (hERG) channels is regulated by caveolin-3 protein via the ubiquitin ligase Nedd4-2. J Biol Chem 2012, 287:33132-33141.
78. Keating M.T., Sanguinetti M.C. Molecular and cellular mechanisms of cardiac arrhythmias. Cell 2001, 104:569-580.
79. Brugada R., Hong K., Dumaine R., Cordeiro J., Gaita F., Borggrefe M., et al. Sudden death associated with short-QT syndrome linked to mutations in HERG. Circulation 2004, 109:30-35.
80. Jespersen T., Membrez M., Nicolas C.S., Pitard B., Staub O., Olesen S.P., et al. The KCNQ1 potassium channel is down-regulated by ubiquitylating enzymes of the Nedd4/Nedd4-like family. Cardiovasc Res 2007, 74:64-74.
81. Krzystanek K., Rasmussen H.B., Grunnet M., Staub O., Olesen S.P., Abriel H., et al. Deubiquitylating enzyme USP2 counteracts Nedd4-2-mediated downregulation of KCNQ1 potassium channels. Heart Rhythm 2012, 9:440-448.
82. Sanguinetti M.C., Tristani-Firouzi M. hERG potassium channels and cardiac arrhythmia. Nature 2006, 440:463-469.
83. Dolmatova E., Mahida S., Ellinor P.T., Lubitz S.A. Genetic etiology and evaluation of sudden cardiac death. Curr Cardiol Rep 2013, 15:389.
84. Popolo A., Morello S., Sorrentino R., Pinto A. Antiadrenergic effect of adenosine involves connexin 43 turn-over in H9c2 cells. Eur J Pharmacol Sep. 5 2013, 715(1-3):56-61. http://dx.doi.org/10.1016/j.ejphar.2013.06.019 [Epub 2013 Jul 5].
85. Srisakuldee W., Nickel B.E., Fandrich R.R., Jiang Z.S., Kardami E. Administration of FGF-2 to the heart stimulates connexin-43 phosphorylation at protein kinase C target sites. Cell Commun Adhes 2006, 13:13-19.
86. Gillet L., Shy D., Abriel H. NaV1.5 and interacting proteins in human arrhythmogenic cardiomyopathy. Future Cardiol 2013, 9:467-470.
87. Chen S.N., Czernuszewicz G., Tan Y., Lombardi R., Jin J., Willerson J.T., et al. Human molecular genetic and functional studies identify TRIM63, encoding muscle RING finger protein 1, as a novel gene for human hypertrophic cardiomyopathy. Circ Res Sep. 14 2012, 111(7):907-919. http://dx.doi.org/10.1161/CIRCRESAHA.112.270207 [Epub 2012 Jul 19].
88. Chen S.N., Rodriguez G., Czernuszewicz G., U.J., Jin J., Marian A.J. TRIM63, encoding MuRF1, is a novel gene for human hypertrophic cardiomyopathy. Circulation 2010, 122:A21194.
89. Mearini G., Gedicke C., Schlossarek S., Witt C.C., Kramer E., Cao P., et al. Atrogin-1 and MuRF1 regulate cardiac MyBP-C levels via different mechanisms. Cardiovasc Res 2010, 85:357-366.
90. Li H.H., Willis M.S., Lockyer P., Miller N., McDonough H., Glass D.J., et al. Atrogin-1 inhibits Akt-dependent cardiac hypertrophy in mice via ubiquitin-dependent coactivation of forkhead proteins. J Clin Invest 2007, 117:3211-3223.
91. Schisler J.C., Willis M.S., Patterson C. You spin me round: MaFBx/Atrogin-1 feeds forward on FOXO transcription factors (like a record). Cell Cycle 2008, 7:440-443.
92. Spence J., Sadis S., Haas A.L., Finley D. A ubiquitin mutant with specific defects in DNA repair and multiubiquitination. Mol Cell Biol 1995, 15:1265-1273.
93. Torres M.P., Lee M.J., Ding F., Purbeck C., Kuhlman B., Dokholyan N.V., et al. G protein mono-ubiquitination by the Rsp5 ubiquitin ligase. J Biol Chem 2009, 284:8940-8950.
94. Shimokawa N., Okada J., Haglund K., Dikic I., Koibuchi N., Miura M. Past-A, a novel proton-associated sugar transporter, regulates glucose homeostasis in the brain. J Neurosci 2002, 22:9160-9165.
95. Leithe E., Rivedal E. Ubiquitination and down-regulation of gap junction protein connexin-43 in response to 12-O-tetradecanoylphorbol 13-acetate treatment. J Biol Chem 2004, 279:50089-50096.
96. Leithe E., Rivedal E. Epidermal growth factor regulates ubiquitination, internalization and proteasome-dependent degradation of connexin43. J Cell Sci 2004, 117:1211-1220.
97. Huang H., Joazeiro C.A., Bonfoco E., Kamada S., Leverson J.D., Hunter T. The inhibitor of apoptosis, cIAP2, functions as a ubiquitin-protein ligase and promotes in vitro monoubiquitination of caspases 3 and 7. J Biol Chem 2000, 275:26661-26664.
98. Jennissen H.P., Laub M. Ubiquitin-calmodulin conjugating activity from cardiac muscle. Biol Chem Hoppe Seyler 1988, 369:1325-1330.
99. Platta H.W., Abrahamsen H., Thoresen S.B., Stenmark H. Nedd4-dependent lysine-11-linked polyubiquitination of the tumour suppressor Beclin 1. Biochem J 2012, 441:399-406.
100. Alberti S., Esser C., Hohfeld J. BAG-1 - a nucleotide exchange factor of Hsc70 with multiple cellular functions. Cell Stress Chaperones 2003, 8:225-231.
101. Takayama S., Bimston D.N., Matsuzawa S., Freeman B.C., Aime-Sempe C., Xie Z., et al. BAG-1 modulates the chaperone activity of Hsp70/Hsc70. EMBO J 1997, 16:4887-4896.
102. Gurusamy N., Lekli I., Gorbunov N.V., Gherghiceanu M., Popescu L.M., Das D.K. Cardioprotection by adaptation to ischaemia augments autophagy in association with BAG-1 protein. J Cell Mol Med 2009, 13:373-387.
103. Galigniana M.D., Harrell J.M., Housley P.R., Patterson C., Fisher S.K., Pratt W.B. Retrograde transport of the glucocorticoid receptor in neurites requires dynamic assembly of complexes with the protein chaperone Hsp90 and is linked to the CHIP component of the machinery for proteasomal degradation. Brain Res Mol Brain Res 2004, 123:27-36.
104. Meacham G.C., Patterson C., Zhang W., Younger J.M., Cyr D.M. The Hsc70 co-chaperone CHIP targets immature CFTR for proteasomal degradation. Nat Cell Biol 2001, 3:100-105.
105. Dickey C.A., Kamal A., Lundgren K., Klosak N., Bailey R.M., Dunmore J., et al. The high-affinity Hsp90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteins. J Clin Invest 2007, 117:648-658.
106. Al-Ramahi I., Lam Y.C., Chen H.K., de Gouyon B., Zhang M., Perez A.M., et al. CHIP protects from the neurotoxicity of expanded and wild-type ataxin-1 and promotes their ubiquitination and degradation. J Biol Chem 2006, 281:26714-26724.
107. Zhou P., Fernandes N., Dodge I.L., Reddi A.L., Rao N., Safran H., et al. ErbB2 degradation mediated by the co-chaperone protein CHIP. J Biol Chem 2003, 278:13829-13837.
108. Kedar V., McDonough H., Arya R., Li H.H., Rockman H.A., Patterson C. Muscle-specific RING finger 1 is a bona fide ubiquitin ligase that degrades cardiac troponin I. Proc Natl Acad Sci U S A 2004, 101:18135-18140.
109. Li H.H., Du J., Fan Y.N., Zhang M.L., Liu D.P., Li L., et al. The ubiquitin ligase MuRF1 protects against cardiac ischemia/reperfusion injury by its proteasome-dependent degradation of phospho-c-Jun. Am J Pathol 2011, 178:1043-1058.
110. Willis M.S., Schisler J.C., Li L., Rodriguez J.E., Hilliard E.G., Charles P.C., et al. Cardiac muscle ring finger-1 increases susceptibility to heart failure in vivo. Circ Res 2009, 105:80-88.
111. Willis M.S., Wadosky K.M., Rodriguez J.E., Schisler J.C., Lockyer P., Hilliard E.G., et al. Muscle ring finger 1 and muscle ring finger 2 are necessary but functionally redundant during developmental cardiac growth and regulate E2F1-mediated gene expression in vivo. Cell Biochem Funct Mar. 20 2013, http://dx.doi.org/10.1002/cbf.2969 [Epub ahead of print].
112. Fielitz J., van Rooij E., Spencer J.A., Shelton J.M., Latif S., van der Nagel R., et al. Loss of muscle-specific RING-finger 3 predisposes the heart to cardiac rupture after myocardial infarction. Proc Natl Acad Sci U S A 2007, 104:4377-4382.
113. Ni Y.G., Berenji K., Wang N., Oh M., Sachan N., Dey A., et al. Foxo transcription factors blunt cardiac hypertrophy by inhibiting calcineurin signaling. Circulation 2006, 114:1159-1168.
114. Li H.H., Kedar V., Zhang C., McDonough H., Arya R., Wang D.Z., et al. Atrogin-1/muscle atrophy F-box inhibits calcineurin-dependent cardiac hypertrophy by participating in an SCF ubiquitin ligase complex. J Clin Invest 2004, 114:1058-1071.
115. Xie P., Guo S., Fan Y., Zhang H., Gu D., Li H. Atrogin-1/MAFbx enhances simulated ischemia/reperfusion-induced apoptosis in cardiomyocytes through degradation of MAPK phosphatase-1 and sustained JNK activation. J Biol Chem 2009, 284:5488-5496.
116. Schisler J.C., Rubel C.E., Zhang C., Lockyer P., Cyr D.M., Patterson C. CHIP protects against cardiac pressure overload through regulation of AMPK. J Clin Invest Aug. 1 2013, 123(8):3588-3599. http://dx.doi.org/10.1172/JCI69080 [Epub 2013 Jul 25].
117. McDonough H., Patterson C. CHIP: a link between the chaperone and proteasome systems. Cell Stress Chaperones 2003, 8:303-308.
118. Zhao B., Sun G., Feng G., Duan W., Zhu X., Chen S., et al. Carboxy terminus of heat shock protein (Hsp) 70-interacting protein (CHIP) inhibits Hsp70 in the heart. J Physiol Biochem 2012, 68:485-491.
119. Woo C.H., Le N.T., Shishido T., Chang E., Lee H., Heo K.S., et al. Novel role of C terminus of Hsc70-interacting protein (CHIP) ubiquitin ligase on inhibiting cardiac apoptosis and dysfunction via regulating ERK5-mediated degradation of inducible cAMP early repressor. FASEB J 2010, 24:4917-4928.
120. Tian L.F., Li H.Y., Jin B.F., Pan X., Man J.H., Zhang P.J., et al. MDM2 interacts with and downregulates a sarcomeric protein, TCAP. Biochem Biophys Res Commun 2006, 345:355-361.
121. Haupt Y., Maya R., Kazaz A., Oren M. Mdm2 promotes the rapid degradation of p53. Nature 1997, 387:296-299.
122. Balasubramanian S., Mani S., Shiraishi H., Johnston R.K., Yamane K., Willey C.D., et al. Enhanced ubiquitination of cytoskeletal proteins in pressure overloaded myocardium is accompanied by changes in specific E3 ligases. J Mol Cell Cardiol 2006, 41:669-679.
123. Potts M.B., Vaughn A.E., McDonough H., Patterson C., Deshmukh M. Reduced Apaf-1 levels in cardiomyocytes engage strict regulation of apoptosis by endogenous XIAP. J Cell Biol 2005, 171:925-930.
124. Witt C.C., Witt S.H., Lerche S., Labeit D., Back W., Labeit S. Cooperative control of striated muscle mass and metabolism by MuRF1 and MuRF2. EMBO J 2008, 27:350-360.
125. Witt S.H., Granzier H., Witt C.C., Labeit S. MURF-1 and MURF-2 target a specific subset of myofibrillar proteins redundantly: towards understanding MURF-dependent muscle ubiquitination. J Mol Biol 2005, 350:713-722.
126. Lange S., Xiang F., Yakovenko A., Vihola A., Hackman P., Rostkova E., et al. The kinase domain of titin controls muscle gene expression and protein turnover. Science 2005, 308:1599-1603.
127. Fielitz J., Kim M.S., Shelton J.M., Latif S., Spencer J.A., Glass D.J., et al. Myosin accumulation and striated muscle myopathy result from the loss of muscle RING finger 1 and 3. J Clin Invest 2007, 117:2486-2495.
128. Rosser M.F., Washburn E., Muchowski P.J., Patterson C., Cyr D.M. Chaperone functions of the E3 ubiquitin ligase CHIP. J Biol Chem 2007, 282:22267-22277.